Qigong for Breast Cancer Survivors
Randomised Controlled Trial of Qigong Training Programme to Alleviate Arm Oedema, ¬Reduce Shoulder Impairment, Improve Body Balance and Quality of Life in Community-dwelling Breast Cancer Survivors
1 other identifier
interventional
60
1 country
1
Brief Summary
Objectives: (1) To investigate the effects of Qigong training on upper limb oedema, circulatory status, shoulder flexibility and muscular strength, body balance, and quality of life (QOL) in community-dwelling breast cancer survivors; and (2) to explore the relationship between the impairment outcomes and QOL outcomes. Hypothesis: (1) The experimental participants will have less impairment and a better QOL after Qigong training compared with the no-training control group; and (2) the impairment parameters will be related to the QOL indexes in the Qigong participants. Design and subjects: This will be a prospective, randomised, single-blinded controlled trial. Approximately 60 breast cancer survivors will be randomly assigned to either the Qigong training group (n\~30) or control group (n\~30). Intervention: Participants in the Qigong group will receive 18 Forms of Tai Chi Internal Qigong training for 3 months with two supervised 1-hour sessions per week. Main outcome measures: The primary outcome measures are upper limb circumference, arterial blood flow velocities and resistance index, shoulder joint passive range of motion, muscular strength (peak force) and body balance. The secondary outcome measure is quality of life as measured by the Functional Assessment of Cancer Therapy - Breast scale. Data analysis: Data will be analysed via repeated-measures analysis of variance followed by post-hoc tests (α = 0.05). Expected results: The investigators pilot studies produced encouraging results on the efficacy of Qigong exercise in reducing chronic breast cancer-related symptoms in survivors. Therefore, the investigators expect that participants in the Qigong group will have fewer upper limb impairments and a better quality of life after Qigong training. If the results are positive, this Qigong training regime is readily transferrable to clinical practice, and could have positive socioeconomic effects such as reduced healthcare costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 9, 2015
CompletedFirst Posted
Study publicly available on registry
April 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedDecember 15, 2015
December 1, 2015
2.2 years
April 9, 2015
December 13, 2015
Conditions
Outcome Measures
Primary Outcomes (5)
Change in upper limb circumference
Circumference of both arms will be measured using a cloth measuring tape.
Baseline (0 month) and post-intervention (3 months)
Change in arterial resistance and blood flow velocities
A Doppler ultrasound machine will be used to examine the arterial blood flow velocities.
Baseline (0 month) and post-intervention (3 months)
Change in shoulder flexibility
A universal goniometer will be used to measure the passive range of motion (ROM) of bilateral shoulder abduction and horizontal abduction.
Baseline (0 month) and post-intervention (3 months)
Change in shoulder muscular strength
The maximum isometric muscular strength of the shoulder flexor, abductor, internal rotator and external rotator muscles will be measured bilaterally using the Lafayette Manual Muscle Test System.
Baseline (0 month) and post-intervention (3 months)
Change in body balance
Standing balance of the participants will be measured using timed single leg standing test.
Baseline (0 month) and post-intervention (3 months)
Secondary Outcomes (1)
Change in quality of life
Baseline (0 month) and post-intervention (3 months)
Study Arms (2)
Qigong training group
EXPERIMENTALParticipants assigned to the Qigong group will receive Qigong training. The Qigong training programme will be run for 3 months with two supervised 1-hour sessions per week. Participants will learn the 18 Forms of Tai Chi Internal Qigong. The training sessions will be conducted by a qualified Qigong instructor from the Natural Health Qigong Association. Participants in the control group will receive no Qigong training during the study period. They will receive an 18 Forms of Tai Chi Internal Qigong training package after the study.
Control group
NO INTERVENTIONParticipants in the control group will receive no Qigong training.
Interventions
Participants will learn the 18 Forms of Tai Chi Internal Qigong. Detailed movement and breathing descriptions of the Qigong training protocol can been found in Mak YK. 18 Forms Tai Chi Qigong \[in Chinese\]. 7th ed. Hong Kong: Wan Li Book Co.; 2012.
Eligibility Criteria
You may qualify if:
- history of a breast malignancy of any stage
- history of mastectomy or lumpectomy with or without adjuvant chemotherapy or radiotherapy
- having completed conventional cancer treatment and medically stable
- no known neurological deficits resulting from breast cancer treatment or other neurological disorders
- persistent lymphoedema defined as a circumference difference greater than 2 cm at any point between the surgical upper limb and contralateral upper limb13
- female aged 18 or above.
You may not qualify if:
- presence of major psychiatric, neurological, musculoskeletal, cardiovascular, peripheral vascular or kidney disorder
- receiving conventional cancer treatments such as chemotherapy or radiotherapy, medications such as diuretics or traditional Chinese medicine
- recurrent cancer or cancer that has spread to another organ
- participation in regular physical activity
- prior experience of Qigong or Tai Chi
- a smoking habit
- pregnancy during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Hong Kong
Pokfulam, Hong Kong
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, DRPC chairperson
Study Record Dates
First Submitted
April 9, 2015
First Posted
April 17, 2015
Study Start
March 1, 2015
Primary Completion
May 1, 2017
Last Updated
December 15, 2015
Record last verified: 2015-12